IDH1 and myelodysplastic syndrome: In addition, when we conducted subgroup analyses, our data illustrated that IDH1 but not IDH2 mutations negatively affected OS 2.21 (95% CI, 1.45–3.38) and LFS 2.65 (95% CI, 1.53–4.59) in patients with MDS.